Dolo-650 makers accused of paying doctors Rs 1k-cr in free gifts to prescribe drugs
The CBDT accused the makers of Dolo tablets of giving away freebies worth roughly Rs 1,000 crore to doctors in exchange for writing prescriptions for their 650 mg anti-inflammatory, fever-reducing drug, and the Supreme Court referred to this as a “serious issue” in its ruling.
APACMed's India Executive Committee elected Meenakshi Nevatia as its new chairperson
Meenakshi Nevatia, Vice President & Managing Director of Stryker India, has been appointed as the new chairperson of the Asia Pacific Medical Technology Association’s India Executive Committee.
Indian pharma unlikely to be impacted by US ranitidine litigation
Sun Pharmaceuticals, Dr. Reddy’s Laboratories, Perrigo, and Teva reached a $5 million settlement with cancer patient Joseph Bayer. This is the first settlement in the ranitidine litigation, which has been ongoing for three years.
Lupin receives approval from USFDA for rufinamide tablets to treat seizures
Lupin Ltd announced that it has received approval from the US Food and Drug Administration to market generic rufinamide tablets in strengths of 100 mg, 200 mg, and 400 mg for the treatment of seizures.
Strides Pharma Science receives FDA approval for generic naproxen sodium softgel capsules
Strides Pharma Science Ltd announced that its wholly-owned subsidiary, Strides Pharma Global Pte Ltd, has received approval from the US Food and Drug Administration for generic naproxen sodium softgel capsules, which are used to treat pain or inflammation.
NDA for momelotinib to treat myelofibrosis approved by USFDA
GSK plc announced that the New Drug Application for momelotinib, a potential new medicine that may address the significant unmet medical needs of myelofibrosis patients with anaemia, had been accepted by the US Food and Drug Administration.
Deep Brain Stimulation programme for Parkinson's patients developed by Aster Medcity & Medtronic
Aster Medcity & India Medtronic have
collaborated to develop a comprehensive and
advanced Deep Brain Stimulation programme in
India for Parkinson’s patients. The collaboration
aims to broaden the program’s reach to include
all Parkinson’s and movement disorder patients.
and then